The Trump administration has confirmed a 2.48% increase to Medicare Advantage payment rates for 2027, a figure substantially higher than the near-flat rate proposed just months ago. The decision, announced by the Centres for Medicare & Medicaid Services on Monday, translates to more than $13 billion in additional payments to private health insurers and marks a significant reversal from January’s initial proposal.
The announcement sent shares in major health insurers sharply higher in after-hours trading. UnitedHealth and CVS Health each rose more than 9%, whilst Humana climbed approximately 12%, a swift market response reflecting how closely the industry had been watching the outcome.
A Sharp Departure from January’s Proposal
When the administration first floated a payment rate increase of just 0.09% in January, the reaction from insurers and investors was swift and hostile. Shares fell, and industry groups warned that a near-zero increase would force companies to exit markets, reduce benefits, or scale back drug coverage plans, moves that could meaningfully limit Medicare beneficiaries’ access to private plan options.
The final rate represents a considerable departure from that position. CMS stated that the finaliased policies reflect “consideration of the various elements that impact MA payments, such as growth rates of underlying costs, 2026 Star Ratings for 2027 quality bonus payments, and risk adjustment updates.” CMS Administrator Dr Mehmet Oz said the updates were designed to “keep coverage affordable and ensure patients get real value from their plans.”
The higher rate follows sustained lobbying efforts by health insurance groups and plan associations, who argued the lower figure would destabilise the market. The health insurance lobby AHIP, responding to the announcement, said plans would “continue to focus on keeping coverage and care as affordable as possible during this time of sharply rising medical costs.”
Why Medicare Advantage Rates Carry Such Weight
Medicare Advantage plans are privately administered alternatives to traditional Medicare, contracted by the federal government to offer standard coverage alongside additional benefits such as dental, vision, wellness programmes, and disease management services. Enrolment has grown substantially, with more than 35 million older adults now covered, exceeding half of all eligible Medicare beneficiaries, according to health policy research organisation KFF.
The payment rate that CMS sets each year is the central mechanism determining how much insurers can charge in monthly premiums and what benefits they are able to offer. It therefore has a direct bearing on the profitability of companies such as UnitedHealth Group’s UnitedHealthcare, CVS Health’s Aetna, Humana, and Elevance Health, all of which have been contending with rising medical costs as enrolment among older adults reaches record levels.
Chris Klomp, Director of Medicare and Chief Counsellor at the Department of Health and Human Services, described the announcement as a step toward “a great choice for seniors and a smart deal for taxpayers,” adding that the rate changes were intended to strengthen competition based on quality rather than on “coding practices.”
Whether the increase proves sufficient to address the cost pressures facing the industry remains to be seen, though Monday’s market reaction suggested investors, at least, were relieved.
